Amvaz, Dafiro, Exforge (amlodipine) is a small molecule pharmaceutical. Amlodipine was first approved as Amvaz on 2003-10-31. It is used to treat coronary artery disease, hypertension, and variant angina pectoris in the USA. It has been approved in Europe to treat hypertension. It is known to target voltage-dependent L-type calcium channel subunit alpha-1D and voltage-dependent L-type calcium channel subunit alpha-1C.
|Trade Name||Dafiro HCT, Exforge HCT|
|Indication||coronary artery disease, hypertension, variant angina pectoris|
|Drug Class||Phenylpyridine vasodilators (nifedipine type)|